elle.m...@gmail.com wrote:
> Over the last 2 days, Genentech (DNA) has risen almost 8% ($7+), the
> highest it's been since 11/19, having been under the shadow of the
> rejected Roche buyout bid, the financing of which has nevertheless
> remained a matter of ongoing speculation.  That speculation has been
> questioning whether Roche could even finance the deal if it were to
> ever go through.  On Thursday 12/18, DNA stock began to rise on no
> apparent news, with commentary found today on another site that
> states: "unsubstantiated market chatter that deal financing for the
> previously announced $89 per share bid from Swiss drug maker, Roche
> may be looking good".  If the latter is true, wouldn't that be
> considered to be insider information?  If not, is there manipulation
> going on?  While I have owned Genentech stock for more than 10 years,
> I will be glad to be done with it because I've seen this sort of
> action too much.  Once 09 rolls in, I will be glad to either cover my
> short call on it and sell or let it be assigned.  I'd rather be in
> another strong biotech that does not seem to be as subject to apparent
> manipulation.